ProQR Therapeutics NV (NASDAQ:PRQR)
| 1.70 Delayed Data As of Jun 09 |  -0.055 / -3.13%Today’s Change | 0.68 Today|||52-Week Range 3.85 | -54.05% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 281.5K | 304.7K | 591.6K | 579.8K | ||
| Operating Expenses | Gross Income | -281.5K | -304.7K | -591.6K | -579.8K | |
| General Expenses | 10.0M | 15.9M | 16.6M | 13.4M | ||
| Research And Development | 7.3M | 10.9M | 13.6M | 10.7M | ||
| Total Operating Expenses | 10.3M | 16.2M | 17.2M | 13.9M | ||
| Non-Operating Expenses | Operating Income | -10.3M | -16.2M | -17.2M | -13.9M | |
| Interest Expense On Debt | 86.1K | 146.1K | -- | 596.7K | ||
| Equity In Earnings | 0.00 | 0.00 | -- | 784.3K | ||
| Other Expenses | 3.4M | 1.5M | 472.4K | 632.6K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -7.0M | -14.8M | -16.2M | -13.9M | |
| Income Taxes | 0.00 | 0.00 | 0.00 | -71.9K | ||
| Minority Interest | -38.4K | -37.7K | -98.8K | -92.1K | ||
| Net Income | -6.9M | -14.8M | -16.1M | -13.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 33.4M | 38.8M | 38.9M | 38.9M | |
| Shares To Calculate EPS Diluted | 33.4M | 38.8M | 38.9M | 38.9M | ||
| Earnings Per Share | EPS | -$0.21 | -$0.38 | -$0.41 | -$0.34 | |
| EPS Diluted | -$0.21 | -$0.38 | -$0.41 | -$0.34 | ||
